Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: An unfulfilled promise

Journal of Urology

Volumn 166, Issue 3, 2001, Pages 841-844

  Cassel, Aliza ^a   Rahat, Michal A ^a   Lahat, Nitza ^a   Lindenfeld, Noemi ^a   Mecz, Yoel ^a   Stein, Avi ^a  

^a CARMEL MEDICAL CENTER   (Israel)

Author keywords

Bladder; Carcinoma, transitional cell; Keratin; Telomerase; Tumor markers, biological

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 8; RNA; TELOMERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; URINALYSIS;

EID: 0034890707     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65848-X     Document Type: Article

References (28)

1. Risk of bladder cancer by source of type of tobacco exposure: A case control study
2. The pathology of human bladder cancer
3. Radical cystectomy with or without polychemotherapy for non organ confined transitional cell carcinoma of the urinary bladder: Prognostic impact of lymphonode involvement
4. Structure and function of telomeres
5. Telomers, telomerase and immortality
6. Telomers shorten during aging of human fibroblasts
7. Telomerase activity in human renal cell carcinoma
8. Specific association of human telomerase activity with immortal cells and cancer
9. Telomerase activity in patients with transitional cell carcinoma: A preliminary study
10. Telomerase activity as a potential marker in preneoplastic bladder lesions
11. Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma
12. Urinary telomerase and its possible role as a marker for bladder cancer
13. Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer
14. Keratin 20: Immunohistochemical marker for gastrointestinal, urothelial and Merkel cell carcinomas
15. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies
16. Cytokeratin 20 as an objective marker of urothelial dysplasia
17. Urinary cytokeratin 20 as a marker for transitional cell carcinoma
18. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma
19. Detection of colorectal carcinoma cells in circulating peripheral blood by reverse transcription-polymerase chain reaction targeting cytokeratin-20 mRNA
20. Telomerase activity: A biomarker of cell proliferation, not malignant transformation
21. Telomerase activity: A biomarker of cell proliferation, not malignant transformation
22. Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation
23. Detection of bladder tumors by immunostaining of the Lewis X antigen in cells from voided urine
24. Blood group antigens in normal and neoplastic urothelium
25. The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms
26. Improved detection of recurrent bladder cancer using the Bard BTA stat test
27. Bladder wash cytology, quantitative cytology and qualitative BTA test in patients with superficial bladder cancer
28. Rapid detection of bladder cancer: A comparative study of point of care tests